A Study of Oral Contraception Under Simulated OTC Conditions

• Status: Terminated
• Trial end date: 2018-11-14
• Target enrollment: 0
• Participant gender: Female

Summary

This study is designed to assess whether consumers select and use norgestrel 0.075 mg, a progestin only pill for contraception, in a manner consistent with the OTC package directions in an Over-the-Counter (OTC)-like setting.

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: HRA Pharma
• Treatments: Norgestrel

Criteria

Inclusion Criteria:

-Women who are willing purchase (in the pharmacies) or be provided (in the clinics) oral contraception for their own use for the purposes of the study

Exclusion Criteria:

• Cannot read, speak and understand English

• Cannot see well enough to read information on the label